Case Study 2
|Title||Stakeholder research in HPV vaccine market|
|Research objective||To determine the preference of four stakeholder groups when given a choice of Human Papillomavirus (HPV) vaccines|
|Research approach|| A mix of qualitative and quantitative research techniques were used with the four stakeholder groups as follows:
As part of the questionnaire design process Vawser and Associates worked with the National Centre for Immunisation Research and Surveillance (NCIRS). A series of face to face depth interviews and group discussions were used to test the structured questionnaires prior to the main fieldwork.
|Results and outcomes||Key findings: The research showed that for the purposes of the National HPV Vaccination program, the vast majority of each stakeholder group would prefer the NSW government to use the current HPV vaccine of the time (Gardasil ®), that provided protection against cervical cancer and genital warts, over an alternative HPV vaccine that provided protection against cervical cancer but not genital warts. The research also showed strong support for the Federal Government's National HPV Vaccination program and a series of other findings of interest.
Outcomes: CSL used the results to illustrate a strong preference for their HPV vaccine (Gardasil ®) to relevant health professionals and government decision makers. As a part of this process the results were presented in poster and oral form at two conferences during 2008.